A multi centre randomized open label trial of chloroquine for the treatment of adults with SARS-CoV-2 infection in Vietnam

<strong>Background:</strong> COVID-19 is a respiratory disease caused by a novel coronavirus (SARS-CoV-2) and causes substantial morbidity and mortality. There is currently no vaccine to prevent COVID-19 or therapeutic agent to treat COVID-19. This clinical trial is designed to evaluate...

Full description

Bibliographic Details
Main Authors:	Kestelyn, E, Dung, NTP, Lam Minh, Y, Hung, LM, Quan, NM, Dung, NT, Minh, NNQ, Xuan, TC, Phong, NT, Ninh Thi Thanh, V, Donovan, J, Tu, TNH, Nhat, LTH, Truong, NT, Man, DNH, Thao, HP, Ngoc, NM, Lam, VT, Phat, HH, Phuong, PM, Geskus, RB, Ha, VTN, Quang, NN, Tran Tinh, H, Tan, LV, Thwaites, GE, Day, JN, Chau, NVV, OUCRU COVID-19 Research Group
Format:	Journal article
Language:	English
Published:	F1000Research 2020

A multi centre randomized open label trial of chloroquine for the treatment of adults with SARS-CoV-2 infection in Vietnam

Similar Items